- Research Article
- 10.1016/j.jval.2024.10.2249
MSR15 A Novel Crossover Adjustment Analysis of Overall Survival Results From the Phase 3 ClarIDHy Study of Ivosidenib Versus Placebo in Patients With MIDH1 Cholangiocarcinoma
- Dec 01, 2024
- Value in Health
- G Prager + 2 more +2
